Drug Database
Back to search

Netherlands· NL-ac3f44d20245

Bupivacaïne HCl Eureco-Pharma 5 mg/ml Glucose, oplossing voor injectie voor intrathecale toediening

A bupivacaine product containing bupivacaïnehydrochloride 1-water + glucose 0-water, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 15 of our 19 countries.

ATC N01BB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBupivacaïne HCl Eureco-Pharma 5 mg/ml…ATCN01BB01REGISTER NO.NL-ac3f44d20245PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bupivacaïnehydrochloride 1-water + glucose 0-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bupivacaine is registered in 15 of 19 countries.

Countries holding a registration under ATC N01BB01 (bupivacaine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search bupivacaine products by name

Bupivacaine · ATC N01BB01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BUPIVACAÏNEHYDROCHLORIDE 1-WATER + GLUCOSE 0-WATER
Manufacturer
Eureco-Pharma B.V.
Country
Netherlands (NL)
ATC code
N01BB01
ATC class
Bupivacaine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    114262//09869

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

97 interactions on record for bupivacaine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check bupivacaine against other medicinesHow interaction checks work

Bupivacaine · interactions on record

97 records

  • 3 severe
  • 31 moderate
  • 1 minor
  • 62 info

Most severe, free to view

  • LidocaineC01BB01severe
  • TetracaineN01BA03severe
  • LidocaineN01BB02severe
  • LidocainA01AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bupivacaine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bupivacaine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Denmark · Marcain Spinal Tung
  • Latvia · Marcaine Spinal Heavy

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0862eae-8bdd-4198-84a0-91fd63350df6
GET /v1/drugs/e0862eae-8bdd-4198-84a0-91fd63350df6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intrathecaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h09869_smpc.pdf",
  "strength": null,
  "atc_label": "Bupivacaine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg114262",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "BUPIVACAÏNEHYDROCHLORIDE 1-WATER",
    "GLUCOSE 0-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h114262.pdf",
  "authorised_at": "2014/03/11",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "114262//09869",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about bupivacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console